2021
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines. Current HIV/AIDS Reports 2021, 19: 5-16. PMID: 34843064, PMCID: PMC8628277, DOI: 10.1007/s11904-021-00590-x.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionSARS-CoV-2Human immune deficiency virus (HIV) infectionSARS-CoV-2 acute infectionImmune systemSevere acute respiratory syndrome coronavirus 2Severe SARS-CoV-2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Chronic HIV infectionSyndrome coronavirus 2Effectiveness of vaccinesHost immune systemCOVID-19 diseaseRecent FindingsPeopleAntiretroviral therapyImmunological changesAcute infectionHIV infectionDisease complicationsPersistent inflammationCoronavirus 2Functional impairmentVirus infectionImmune response
2019
Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat
Taura M, Song E, Ho YC, Iwasaki A. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 2282-2289. PMID: 30670656, PMCID: PMC6369738, DOI: 10.1073/pnas.1819386116.Peer-Reviewed Original ResearchMeSH KeywordsCD4-Positive T-LymphocytesCell LineCytidine DeaminaseEpigenesis, GeneticGene Expression Regulation, ViralGene SilencingHIV InfectionsHIV Long Terminal RepeatHIV-1HumansNF-kappa BProtein BindingProtein Interaction Domains and MotifsProteinsSequence DeletionSp1 Transcription FactorVirus ActivationVirus LatencyConceptsHIV-1 latencyHIV-1 reactivationCD4 T cellsT cellsHuman primary CD4 T cellsInfected CD4 T cellsHIV-1-infected cellsPrimary CD4 T cellsLong terminal repeat regionHIV-1Therapeutic strategiesLower reactivationProviral DNALatency maintenanceTarget cellsLatency stateCell linesLong terminal repeatTerminal repeat regionMolecular mechanismsReactivationCellsKnockdownA3AUnexpected role
2012
Innate Immune Recognition of HIV-1
Iwasaki A. Innate Immune Recognition of HIV-1. Immunity 2012, 37: 389-398. PMID: 22999945, PMCID: PMC3578946, DOI: 10.1016/j.immuni.2012.08.011.Peer-Reviewed Original Research
2006
A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN–based vaginal microbicide
Shen H, Iwasaki A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN–based vaginal microbicide. Journal Of Clinical Investigation 2006, 116: 2237-2243. PMID: 16878177, PMCID: PMC1518794, DOI: 10.1172/jci28681.Peer-Reviewed Original ResearchConceptsCpG ODNPlasmacytoid DCsHerpes simplex virus type 2Simplex virus type 2Lethal vaginal challengeVaginal stromal cellsPlasmacytoid dendritic cellsGenital herpes infectionIFN-alphabeta receptorAssociated inflammatory responseVirus type 2Vaginal challengeDendritic cellsHerpes infectionTLR agonistsMicrobicide efficacyTopical microbicidesVaginal microbicidesInflammatory responseI IFNAntiviral protectionType 2Antiviral genesStromal compartmentVaginal application